Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Pharmacogenomics: Precision Pharmacy in 503A Compounding

Author(s):  Drummond Joseph, Bennet Daron, Allen Loyd V Jr

Issue:  Mar/Apr 2018 - Volume 22, Number 2
View All Articles in Issue

Abstract:  The first recorded mention of a pharmacogenomic response may be that of Pythagoras in 510 BC, when he noted that hemolytic anemia developed in some but not all people who ingested fava beans. The application of such accounts to pharmacotherapy was inevitable, and customized medications have been compounded since antiquity to treat the needs of individual patients. Today, advances in pharmacogenomic testing yield results that enable more effective targeted therapies sooner in the course of treatment, prevent drug-related adverse effects, save cost, and ensure a better therapeutic outcome. The value of such testing is now more widely accepted, even in the public domain. It is our opinion that third-party payors will realize, to an increasing degree, that this new technology will save them money and will pay for it. Because independent compounding pharmacists have trusted relationships with patients and are convenient to visit, they are well placed to offer certain types of pharmacogenomic tests to patients and prescribers. In this article, topics that we address include the difference between pharmacogenomics and pharmacogenetics; the use of pharmacogenomic testing in 503A compounding; the benefits of such tests for patients, prescribers, and compounders; and suggestions for marketing pharmacogenomics testing. Information about a course that introduces pharmacogenomic science to compounders is provided, and suggestions for additional reading and other resources about pharmacogenomic testing are included for easy reference.

Related Keywords: Joseph Drummond, PharmD, Daron Bennet, Loyd V. Allen Jr., PhD, RPh, precision medicine, customized medications, personalized medicine, pharmacogenomic testing, pharmacogenetics, continuing education, drug-gene interactions, drug-drug interactions, drug-lifestyle interactions, drug safety, adverse effects, side effects

Related Categories: BUSINESS, MARKETING, TECHNOLOGY, PATIENT ASSESSMENT, PROFESSIONAL ISSUES, INFORMATION RESOURCES

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Pharmacogenomics: Precision Pharmacy in 503A Compounding Drummond Joseph, Bennet Daron, Allen Loyd V Jr Mar/Apr 2018 95-107 Buy
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun Mar/Apr 2018 108-121 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106-113 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R Jan/Feb 2020 30-36 Buy
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W May/Jun 2016 202-206 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
PreScription: Discontinued Drugs and Drug Shortages Allen Loyd V Jr Mar/Apr 2011 92 Buy
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A Jul/Aug 2012 294-298 Buy